Brief: Creso Pharma Records Qtrly Total Group Revenue Of A$2.1 Million
Nov 1 (Reuters) - Creso Pharma Ltd CPH.AX :
* QTRLY TOTAL GROUP REVENUE OF A$2.1 MILLION, UP 77.0%
Further company coverage: CPH.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale